Skip to content
Home/Companies/Pharma/Axpharma
Axpharma

Axpharma

Pharma·France·Exited 2020·Held 5yr
Entry
2015
Hold
5yr
Exit
2020

Who owns Axpharma?

Axpharma is a French Pharma company, now owned by ProductLife Group (backed by 21 Invest), which acquired it in 2020 from Galiena Capital.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Galiena Capital
Investor
Galiena Capital
FPCI Galiena III · 2025

Key facts

HQFrance
SectorPharma
StatusAcquired
Websiteaxpharma.com.w2fr.com
Exit Type
Trade Sale
Buyer
ProductLife Group (backed by 21 Invest)
Exit Year
2020

More from FPCI Galiena III

Other portfolio companies in the same fund.

Groupe Flore
Active
IndustrialsFrance· 2026
Groupe Thomas Plants
Active
ConsumerFrance· 2026
Thomas Plants
Thomas Plants
Active
AgricultureFrance· 2026
ERTF
Active
Business ServicesFrance· 2025
Ediser
Ediser
Active
EducationFrance· 2024
TOPIA (PEC Paysage)
Active
Business ServicesFrance· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Axpharma?

Axpharma is now owned by ProductLife Group (backed by 21 Invest), which acquired it in 2020 from Galiena Capital.

When did ProductLife Group (backed by 21 Invest) acquire Axpharma?

ProductLife Group (backed by 21 Invest) acquired Axpharma in 2020, buying from Galiena Capital.

Who did Axpharma sell to?

Galiena Capital sold Axpharma to ProductLife Group (backed by 21 Invest) in 2020 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue